Getinge AB (publ) (GETI-B.ST)
SEK 174.85
(2.01%)
SEK 174.85
(2.01%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.07 Billion SEK | 38.67% |
| 2022 | 5.82 Billion SEK | 35.25% |
| 2021 | 4.3 Billion SEK | -57.81% |
| 2020 | 10.2 Billion SEK | 1.86% |
| 2019 | 10.02 Billion SEK | -7.47% |
| 2018 | 10.82 Billion SEK | -3.63% |
| 2017 | 11.23 Billion SEK | -48.22% |
| 2016 | 21.7 Billion SEK | 1.96% |
| 2015 | 21.28 Billion SEK | 2.56% |
| 2014 | 20.75 Billion SEK | 20.86% |
| 2013 | 17.16 Billion SEK | -2.03% |
| 2012 | 17.52 Billion SEK | 5.01% |
| 2011 | 16.68 Billion SEK | 31.87% |
| 2010 | 12.65 Billion SEK | -21.16% |
| 2009 | 16.05 Billion SEK | 22.07% |
| 2008 | 13.15 Billion SEK | 42.73% |
| 2007 | 9.21 Billion SEK | 108.53% |
| 2006 | 4.41 Billion SEK | 7.52% |
| 2005 | 4.1 Billion SEK | 11.11% |
| 2004 | 3.69 Billion SEK | 13.97% |
| 2003 | 3.24 Billion SEK | 34.36% |
| 2002 | 2.41 Billion SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 8.33 Billion SEK | 3.16% |
| 2024 Q3 | 9.13 Billion SEK | 26.21% |
| 2024 Q2 | 8.61 Billion SEK | 3.36% |
| 2023 Q3 | 6.81 Billion SEK | -1.15% |
| 2023 Q1 | 5.81 Billion SEK | -0.14% |
| 2023 Q2 | 6.89 Billion SEK | 18.52% |
| 2023 FY | 8.07 Billion SEK | 38.67% |
| 2023 Q4 | 8.07 Billion SEK | 18.52% |
| 2022 Q2 | 5.38 Billion SEK | 25.62% |
| 2022 Q3 | 5.49 Billion SEK | 2.04% |
| 2022 FY | 5.82 Billion SEK | 35.25% |
| 2022 Q4 | 5.82 Billion SEK | 5.91% |
| 2022 Q1 | 4.29 Billion SEK | -0.37% |
| 2021 Q1 | 8.08 Billion SEK | -20.82% |
| 2021 Q4 | 4.3 Billion SEK | -22.48% |
| 2021 Q3 | 5.55 Billion SEK | 0.85% |
| 2021 FY | 4.3 Billion SEK | -57.81% |
| 2021 Q2 | 5.5 Billion SEK | -31.84% |
| 2020 Q2 | 13.28 Billion SEK | 19.53% |
| 2020 Q4 | 10.2 Billion SEK | -15.2% |
| 2020 FY | 10.2 Billion SEK | 1.86% |
| 2020 Q1 | 11.11 Billion SEK | 10.9% |
| 2020 Q3 | 12.03 Billion SEK | -9.38% |
| 2019 Q4 | 10.02 Billion SEK | -13.86% |
| 2019 FY | 10.02 Billion SEK | -7.47% |
| 2019 Q3 | 11.63 Billion SEK | -0.54% |
| 2019 Q2 | 11.69 Billion SEK | 0.03% |
| 2019 Q1 | 11.69 Billion SEK | 7.96% |
| 2018 Q2 | 11.56 Billion SEK | 5.63% |
| 2018 Q3 | 10.73 Billion SEK | -7.18% |
| 2018 FY | 10.82 Billion SEK | -3.63% |
| 2018 Q4 | 10.82 Billion SEK | 0.9% |
| 2018 Q1 | 10.94 Billion SEK | -2.59% |
| 2017 Q1 | 21.72 Billion SEK | 0.12% |
| 2017 Q4 | 11.23 Billion SEK | -30.41% |
| 2017 Q3 | 16.14 Billion SEK | -22.73% |
| 2017 Q2 | 20.89 Billion SEK | -3.82% |
| 2017 FY | 11.23 Billion SEK | -48.22% |
| 2016 Q4 | 21.7 Billion SEK | -1.04% |
| 2016 Q3 | 21.92 Billion SEK | -0.64% |
| 2016 Q1 | 21.73 Billion SEK | 2.1% |
| 2016 FY | 21.7 Billion SEK | 1.96% |
| 2016 Q2 | 22.07 Billion SEK | 1.57% |
| 2015 Q1 | 22.27 Billion SEK | 7.35% |
| 2015 FY | 21.28 Billion SEK | 2.56% |
| 2015 Q4 | 21.28 Billion SEK | -2.81% |
| 2015 Q3 | 21.89 Billion SEK | 1.41% |
| 2015 Q2 | 21.59 Billion SEK | -3.07% |
| 2014 Q2 | 19.09 Billion SEK | 17.83% |
| 2014 Q1 | 16.2 Billion SEK | -5.61% |
| 2014 FY | 20.75 Billion SEK | 20.86% |
| 2014 Q4 | 20.75 Billion SEK | 3.77% |
| 2014 Q3 | 19.99 Billion SEK | 4.73% |
| 2013 Q3 | 16.22 Billion SEK | -12.91% |
| 2013 Q2 | 18.63 Billion SEK | 0.0% |
| 2013 Q1 | - SEK | -100.0% |
| 2013 FY | 17.16 Billion SEK | -2.03% |
| 2013 Q4 | 17.16 Billion SEK | 5.82% |
| 2012 Q1 | - SEK | -100.0% |
| 2012 Q2 | - SEK | 0.0% |
| 2012 Q3 | - SEK | 0.0% |
| 2012 FY | 17.52 Billion SEK | 5.01% |
| 2012 Q4 | 17.52 Billion SEK | 0.0% |
| 2011 Q1 | - SEK | -100.0% |
| 2011 Q4 | 16.68 Billion SEK | 0.0% |
| 2011 FY | 16.68 Billion SEK | 31.87% |
| 2011 Q3 | - SEK | 0.0% |
| 2011 Q2 | - SEK | 0.0% |
| 2010 Q1 | - SEK | -100.0% |
| 2010 FY | 12.65 Billion SEK | -21.16% |
| 2010 Q4 | 12.65 Billion SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2009 Q4 | 16.05 Billion SEK | 0.0% |
| 2009 FY | 16.05 Billion SEK | 22.07% |
| 2008 FY | 13.15 Billion SEK | 42.73% |
| 2007 FY | 9.21 Billion SEK | 108.53% |
| 2006 FY | 4.41 Billion SEK | 7.52% |
| 2005 FY | 4.1 Billion SEK | 11.11% |
| 2004 FY | 3.69 Billion SEK | 13.97% |
| 2003 FY | 3.24 Billion SEK | 34.36% |
| 2002 FY | 2.41 Billion SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | -400.558% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | -400.558% |
| Arcoma AB | 3.87 Million SEK | -208420.527% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | -3364.622% |
| BICO Group AB (publ) | 1.85 Billion SEK | -335.81% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | -4762.131% |
| CellaVision AB (publ) | 64.7 Million SEK | -12381.647% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -1778754.626% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -448566.667% |
| Duearity AB (publ) | 10.58 Million SEK | -76218.276% |
| Dignitana AB (publ) | 19.1 Million SEK | -42173.869% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -155207.692% |
| Scandinavian Real Heart AB (Publ) | 8.24 Million SEK | -97795.359% |
| Iconovo AB (publ) | 7.72 Million SEK | -104444.907% |
| Integrum AB (publ) | 6.42 Million SEK | -125612.523% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -3919831.658% |
| Mentice AB (publ) | 9.55 Million SEK | -84403.505% |
| OssDsign AB (publ) | 3.15 Million SEK | -256280.952% |
| Paxman AB (publ) | 13.57 Million SEK | -59413.633% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | -38856.153% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -118717.125% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | -25305.814% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -187452.253% |
| Senzime AB (publ) | 11.46 Million SEK | -70322.044% |
| SpectraCure AB (publ) | 6.71 Million SEK | -120132.247% |
| Stille AB | 62.94 Million SEK | -12730.86% |
| Vitrolife AB (publ) | 2.08 Billion SEK | -286.596% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | -25589.474% |